ERBB2 SUPPRESSION DECREASES CELL GROWTH VIA APOPTOSIS IN GASTROINTESTINAL ADENOCARCINOMAS

While the incidence of esophageal and GE junction adenocarcinomas have increased at an alarming rate in the past 30 years, little improvement has been made in treatment strategies. Previous studies have shown that many upper gastrointestinal adenocarcinomas exhibit ERBB2 amplification. In cancers pr...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Surgery
Main Authors: Arrington, A. K., Dahlberg, P. S., Davydova, J., Vickers, S. M., Yamamoto, M.
Formato: Artigo
Idioma:Inglês
Publicado: 2009
Assuntos:
Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC4569097/
https://ncbi.nlm.nih.gov/pubmed/19628076
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.surg.2009.04.008
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares